Invention Grant
- Patent Title: Compounds having CRTH2 antagonist activity
- Patent Title (中): 具有CRTH2拮抗活性的化合物
-
Application No.: US13180157Application Date: 2011-07-11
-
Publication No.: US08268878B2Publication Date: 2012-09-18
- Inventor: Richard Edward Armer , Graham Michael Wynne , Colin Richard Dorgan , Peter David Johnson
- Applicant: Richard Edward Armer , Graham Michael Wynne , Colin Richard Dorgan , Peter David Johnson
- Applicant Address: GB Abingdon
- Assignee: Oxagen Limited
- Current Assignee: Oxagen Limited
- Current Assignee Address: GB Abingdon
- Agency: Sterne, Kessler, Goldstein & Fox PLLC
- Priority: GB0614608.8 20060722; GB0624176.4 20061204
- Main IPC: A61K31/40
- IPC: A61K31/40 ; C07D209/04
Abstract:
Compounds of general formula (I) wherein R is phenyl optionally substituted with one or more halo substituents; and their pharmaceutically acceptable salts, hydrates, solvates, complexes or prodrugs are useful in orally administrable compositions for the treatment of allergic diseases such as asthma, allergic rhinitis and atopic dermatitis.
Public/Granted literature
- US20110268693A1 Compounds Having CRTH2 Antagonist Activity Public/Granted day:2011-11-03
Information query
